# Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell

> **NCT00518934** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center**

## Conditions studied

- Ischemia

## Interventions

- **OTHER:** Study for safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cell

## Key facts

- **NCT ID:** NCT00518934
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518934, "Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00518934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*